Sandborn William J. 4
4 · Ventyx Biosciences, Inc. · Filed Aug 8, 2023
Insider Transaction Report
Form 4
Sandborn William J.
See Remarks
Transactions
- Sale
Common Stock
2023-08-08$32.69/sh−2,086$68,181→ 25,602 total(indirect: By Spouse) - Sale
Common Stock
2023-08-08$33.12/sh−1,408$46,628→ 24,194 total(indirect: By Spouse)
Holdings
- 48,389
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on December 19, 2022.
- [F2]Represents the weighted average share price of an aggregate total of 2,086 shares sold in the price range of $32.0441 to $33.0225. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 1,408 shares sold in the price range of $33.055 to $33.37. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.